Mindray Medical International Limited (NYSE: MR), a Chinese medical device manufacturer focusing on patient monitoring products, in vitro diagnostic products and medical imaging systems, recently announced the completion of its acquisition of Wuhan Dragonbio Surgical Implant’s orthopedics business. The companies had previously reached agreement on the acquisition in June. Mindray reportedly paid $35.5 million for a controlling stake in Dragonbio.
Register Now As you are not an existing subscriber please register for your free daily legal newsfeed service.Register
If you have any questions about the service please contact email@example.com or call Lexology Customer Services on +44 20 7234 0606.
Mindray Medical completes acquisition of Dragonbio’s orthopedics business (www.beckersasc.com 2012-07-19) --- July 23, 2012
- Reed Smith LLP
- Jay J. Yan, Hugh Scogin, John Tan, Katherine Yang, May Ling Wong and Gordon B. Schatz
- August 8 2012
If you are interested in submitting an article to Lexology, please contact Andrew Teague at firstname.lastname@example.org.
Bosch & Siemens Home Appliances Group